Skip to content
Search

Latest Stories

Akshay Kumar on wearing a saree in Laxmmi Bomb: It's quite graceful

Akshay Kumar starrer Laxmmi Bomb will be releasing on Disney+ Hotstar. Today, during a live Instagram chat, the actor announced the film’s release and spoke about wearing a saree in the movie.

During the live chat, when Varun Dhawan asked Akshay about how was his experience of wearing a saree in the film, the actor said, "In one word, I'd say it's quite graceful and also, the most comfortable outfit in the world. Saree pehna apne aap mein experience tha. Initially, I couldn't walk and kaafi baar while shooting, saree khul bhi jaati thi. Thankfully, my dress dada was always ready for my rescue. But I think one should experience this. Hats off to the Indian women who wear it so beautifully.”


Further talking about the role, Akshay revealed that it is one of the toughest characters, he has played. He said, "Mere 30 saal ke career mein, mentally sabse tough character raha hai yeh. I give the credit to my director. Maine willingly kaafi takes and retakes liye hai to justify the character. The film has also made me aware to be kind towards the transgender community.”

Laxmmi Bomb is a remake of Tamil film Muni 2: Kanchana. It is directed by Raghava Lawrence who had also directed the original movie. Laxmmi Bomb also stars Kiara Advani in the lead role.

The movie was earlier slated to hit the screens on Eid this year, but due to the lockdown, the release date was pushed. However, now fans of Akshay will get to enjoy the movie on the OTT platform, Disney+ Hotstar.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less